Brophy Wealth Management’s United Therapeutics UTHR Stock Holding History

Brophy Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$809K	Buy	+2,258	New	+$763K	0.29%	86

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Brophy Wealth Management's UTHR Position: Q3 2024 in Review

Brophy Wealth Management opened a new position in United Therapeutics (UTHR) in Q3 2024: 2,258 shares worth $809K. The stake represents 0.29% of the portfolio and ranks #86 among its holdings.

624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

Brophy Wealth Management held 2,258 shares of United Therapeutics worth $809K as of Q3 2024.
United Therapeutics was a new Brophy Wealth Management position in Q3 2024.
United Therapeutics made up 0.29% of Brophy Wealth Management's portfolio in Q3 2024, its #86 holding.
624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Brophy Wealth Management's 13F filing for Q3 2024, filed 15 Nov 2024.